Literature DB >> 3066394

Gastric cancer--the recognition of a chemosensitive tumour.

D Cunningham1.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3066394      PMCID: PMC2246874          DOI: 10.1038/bjc.1988.292

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  38 in total

1.  The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric carcinoma.

Authors:  W P Longmire; J W Kuzma; W J Dixon
Journal:  Ann Surg       Date:  1968-03       Impact factor: 12.969

2.  Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.

Authors:  L L Gunderson; H Sosin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

3.  Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.

Authors:  H W Bruckner; J J Lokich; D M Stablein
Journal:  Cancer Treat Rep       Date:  1982-09

4.  A phase II study of cisplatin in advanced gastric cancer.

Authors:  M Beer; G Cocconi; G Ceci; M Varini; F Cavalli
Journal:  Eur J Cancer Clin Oncol       Date:  1983-06

5.  Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology, Group report.

Authors:  G A Higgins; J H Amadeo; D E Smith; E W Humphrey; R J Keehn
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860

6.  An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group.

Authors:  J W Fielding; S L Fagg; B G Jones; D Ellis; M S Hockey; A Minawa; V S Brookes; J L Craven; M C Mason; A Timothy; J A Waterhouse; P F Wrigley
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

7.  Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).

Authors:  J D Boice; M H Greene; J Y Killen; S S Ellenberg; R J Keehn; E McFadden; T T Chen; J F Fraumeni
Journal:  N Engl J Med       Date:  1983-11-03       Impact factor: 91.245

8.  Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

9.  Studies in prognostic factors relating to chemotherapy for advanced gastric cancer.

Authors:  P T Lavin; H W Bruckner; S C Plaxe
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

10.  Confirmed activity of FAM polychemotherapy in advanced gastric carcinoma.

Authors:  P Fraschini; G Beretta; E Arnoldi; L Tedeschi; R Labianca; G Luporini
Journal:  Tumori       Date:  1983-02-28
View more
  1 in total

1.  Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.

Authors:  D Alexander; T Yamamoto; S Kato; S Kasai
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.